Activity of Various Fractions of Saussurea Lappa Herb Against Multidrug Resistant Gram Negative Rods
S. Lappa against MDR Gram Negative Rods
DOI:
https://doi.org/10.37978/tijfs.v6i1.407Keywords:
aussurea lappa herb, MDR, multidrug resistance, gram naegative rods, GNR, Carbapenemase producing organisms, Methanol, n-hexane, chloroformAbstract
Background: Microorganisms are turning out to be greatly resistant to existing antibiotics, specifically gram-negative rods which shows resistance to currently accessible antibiotics. Beta-lactam antibiotics are the main therapeutic option to treat infections of gram-negative microorganisms i.e., ESBL and Carbapenemase producers. Saussurea lappa herb is a medicinal herb use since many times. Basically, the roots of S. lappa herb were used as medicines. Current study was conducted to find out activity of various fractions of S. lappa herb against multidrug resistant gram-negative rods.
Methods: Crude extracts of ethanol, methanol and water and fractions of n-hexane, chloroform, and methanol from S. lappa herb were used. Total of sixty multidrug resistant organisms were included in which thirty were ESBL and thirty were carbapenemase producing organisms. Mean MIC and comparative analysis of various extracts and fractions have been evaluated.
Results: The mean MIC value of crude extracts of ethanol, methanol, n-hexane, chloroform and methanol fractions and water extract from S. lappa against ESBL producing organisms were 109.33± 6.915 mg/ml, 154.67± 5.164 mg/ml, 150.00± 5.345 mg/ml, 55.33±5.164 mg/ml, 178.00±6.103 mg/ml, 64.00± 7.701 mg/ml respectively. Similarly, the mean MIC value against carbapenemase producing organisms were 100.67± 8.683 mg/ml, 158.67± 3.519 mg/ml, 150.67± 5.936 mg/ml, 54.67±5.164 mg/ml, 176.67±14.223 mg/ml, 64.33± 9.353 mg/ml respectively.
Conclusion: This study suggests that extracts and fractions of S. lappa herb can form the basis to develop novel broad-spectrum formulation for antimicrobial drugs as it contains compounds that has novelty to perform its action against multi-resistant mechanisms.
Downloads
References
Berezin EN, Solórzano F. Gram-negative infections in pediatric and neonatal intensive care units of Latin America. The Journal of Infection in Developing Countries. 2014 Aug 13;8(08):942-53.
Östholm Balkhed Å. Extended-Spectrum ß-Lactamase-Producing Enterobacteriaceae: Antibiotic consumption, Detection and Resistance Epidemiology (Doctoral dissertation, Linköping University Electronic Press).
Ventola CL. The antibiotic resistance crisis: part 2: management strategies and new agents. Pharmacy and Therapeutics. 2015 May;40(5):344.
Tenover FC. Mechanisms of antimicrobial resistance in bacteria. The American journal of medicine. 2006 Jun 1;119(6):S3-10.
Bush K. Alarming ?-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Current opinion in microbiology. 2010 Oct 1;13(5):558-64.
Paterson DL. Resistance in gram-negative bacteria: Enterobacteriaceae. American journal of infection control. 2006 Jun 1;34(5):S20-8.
Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, Bonomo RA, Rice LB. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum ?-lactamases. Clinical infectious diseases. 2004 Jul 1;39(1):31-7.
Rossi F, Baquero F, Hsueh PR, Paterson DL, Bochicchio GV, Snyder TA, Satishchandran V, McCarroll K, DiNubile MJ, Chow JW. In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). Journal of Antimicrobial Chemotherapy. 2006 Jul 1;58(1):205-10.
National Nosocomial Infections Surveillance (NNIS) System R. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 through June 2004, issued October 2004. Am J infect control. 2004;32:470-85.
Kumar VP, Chauhan NS, Padh H, Rajani M. Search for antibacterial and antifungal agents from selected Indian medicinal plants. Journal of ethnopharmacology. 2006 Sep 19;107(2):182-8.
Sarwat SZ, Ahmad N. Screening of potential medicinal plants from district sawat specific for controlling women diseases. Pak J Bot. 2012 Aug 15;44(4):1193-8.
Burt S. Essential oils: their antibacterial properties and potential applications in foods—a review. International journal of food microbiology. 2004 Aug 1;94(3):223-53.
Rao RN, Raju SS, Babu KS, Vadaparthi PR. HPLC determination of costunolide as a marker of Saussurea lappa and its herbal formulations. Int J Biochem. 2013;3(1):99-107.
Wang F, Xie ZH, Gao Y, Xu Y, Cheng XL, Liu JK. Sulfonated guaianolides from Saussurea lappa. Chemical and Pharmaceutical Bulletin. 2008 Jun 1;56(6):864-5.
Hancock RE. Mechanisms of action of newer antibiotics for Gram-positive pathogens. The Lancet infectious diseases. 2005 Apr 1;5(4):209-18.
Kowalska-Krochmal B, Dudek-Wicher R. The minimum inhibitory concentration of antibiotics: Methods, interpretation, clinical relevance. Pathogens. 2021 Feb 4;10(2):165.
Satlin MJ, Lewis JS, Weinstein MP, Patel J, Humphries RM, Kahlmeter G, Giske CG, Turnidge J. Clinical and Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing position statements on polymyxin B and colistin clinical breakpoints. Clinical Infectious Diseases. 2020 Nov 1;71(9):e523-9.
Nagayama A, Yamaguchi K, Watanabe K, Tanaka M, Kobayashi I, Nagasawa Z. Final report from the Committee on Antimicrobial Susceptibility Testing, Japanese Society of Chemotherapy, on the agar dilution method (2007). Journal of infection and chemotherapy. 2008 Jan 1;14(5):383-92.
Andrews J. BSAC Working Party Report on Susceptibility Testing. 2001. Determination of inhibitory concentrations. J. Antimicrob. Chemother.;48:48-71.
EUCAST. European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID): terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents. Clin Microbiol Infec. 2003;9:1-7.
Wiegand I, Hilpert K, Hancock RE. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nature protocols. 2008 Feb;3(2):163-75.
Patel JB. Performance standards for antimicrobial susceptibility testing; twenty-fifth informational supplement.
Hasson SS, Al-Balushi MS, Al-Busaidi J, Othman MS, Said EA, Habal O, Sallam TA, Aljabri AA, AhmedIdris M. Evaluation of anti–resistant activity of Auklandia (Saussurea lappa) root against some human pathogens. Asian Pacific Journal of Tropical Biomedicine. 2013 Jul 1;3(7):557-62.
Rahman MA, Sultana R, Bin Emran T, Islam MS, Rahman MA, Chakma JS, Rashid HU, Hasan CM. Effects of organic extracts of six Bangladeshi plants on in vitro thrombolysis and cytotoxicity. BMC complementary and alternative medicine. 2013 Dec;13:1-7.
Rashid U, Khan MR, Jan S, Bokhari J, Shah NA. Assessment of phytochemicals, antimicrobial and cytotoxic activities of extract and fractions from Fagonia olivieri (Zygophyllaceae). BMC complementary and alternative medicine. 2013 Dec;13:1-7.
Rojas JJ, Ochoa VJ, Ocampo SA, Muñoz JF. Screening for antimicrobial activity of ten medicinal plants used in Colombian folkloric medicine: A possible alternative in the treatment of non-nosocomial infections. BMC complementary and alternative medicine. 2006 Dec;6(1):1-6.
Adebiyi AO, Koekemoer T, Adebiyi AP, Smith N, Baxter E, Naude RJ, Van de Venter M. Antimicrobial and antioxidant activities of crude extracts of two Nigerian chewing sticks. Pharmaceutical Biology. 2009 Apr 1;47(4):320-7.
Kang CG, Hah DS, Kim CH, Kim YH, Kim E, Kim JS. Evaluation of antimicrobial activity of the methanol extracts from 8 traditional medicinal plants. Toxicological research. 2011 Mar;27:31-6.
Panda SK. Screening methods in the study of antimicrobial properties of medicinal plants. International Journal of Biotechnology and Research. 2012;2(1):1-35.
Alaagib RM, Ayoub SM. On the chemical composition and antibacterial activity of Saussurea lappa (Asteraceae). The Pharma Innovation. 2015 Apr 1;4(2, Part C):73.
Chang KM, Choi SI, Chung SJ, Kim GH. Anti-microbial activity of Saussurea lappa CB Clarke roots. Journal of Food Science and Nutrition. 2011 Dec;16(4):376-80.
Mukherjee S, Dey A, Das T. In vitro antibacterial activity of n-hexane fraction of methanolic extract of Alstonia scholaris LR Br. stem bark against some multidrug resistant human pathogenic bacteria. European Journal of Medicinal Plants. 2012 Jan 1;2(1):1.
Duraipandiyan V, Abdullah Al-Harbi N, Ignacimuthu S, Muthukumar C. Antimicrobial activity of sesquiterpene lactones isolated from traditional medicinal plant, Costus speciosus (Koen ex. Retz.) Sm. BMC complementary and alternative medicine. 2012 Dec;12(1):1-6.
Rathi SG, Patel KR, Bhaskar VH. Isolation of herbal plants: antifungal and antibacterial activities. Journal of Pharmaceutical Science and Bioscientific Research. 2012;2(1):25-9.
Sarwar A, Enbergs H. Effects of Saussurea lappa roots extract in ethanol on leukocyte phagocytic activity, lymphocyte proliferation and interferon-gamma (IFN-gamma). Pak J Pharm Sci. 2007 Jul 1;20(3):175-9.
Alam MA, Sarder M, Awal MA, Sikder MM, Daulla KA. Antibacterial activity of the crude ethanolic extract of Xylocarpus granatum stem barks. Bangladesh Journal of Veterinary Medicine. 2006;4(1):69-7
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 The International Journal of Frontier Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
